The search for variants of BACH2 could be a part of the early diagnosis panel that identifies individuals prone to develope a polyglandular autoimmunity, including those already diagnosed with an autoimmune disorder or in first-degree relatives of patients with APS. This evidence concerns the gene BACH2 and autoimmune polyendocrinopathy.